SCHEMBL9636261

SCHEMBL9636261

O=S(=O)(NCCNC/C=C/c1ccccc1)c1cccc2cnccc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 6/20 0.83
PRKCG P05129 5/20 0.83
PRKCZ Q05513 5/20 0.83
PRKCD Q05655 5/20 0.83
ROCK2 O75116 4/20 0.83
PRKACG P22612 4/20 0.83
PRKACB P22694 4/20 0.83
PRKD3 O94806 4/20 0.83
PRKCB P05771 4/20 0.83
PRKCA P17252 4/20 0.83
PRKCH P24723 4/20 0.83
PRKCI P41743 4/20 0.83
PRKCE Q02156 4/20 0.83
PRKCQ Q04759 4/20 0.83
PRKD1 Q15139 4/20 0.83
MAPK1 P28482 3/20 0.83
AKT2 P31751 3/20 0.83
AKT3 Q9Y243 3/20 0.83
SMN1; SMN2 Q16637 3/20 0.83
CYP3A4 P08684 3/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9636264 1.00 PRKACA (0.83) PRKACAPRKCGPRKCZPRKCDROCK2
SCHEMBL29967929 0.91 PRKACA (1.00) PRKACAPRKCGPRKCZPRKCDROCK2
SCHEMBL123495 0.91 PRKACA (1.00) PRKACAPRKCGPRKCZPRKCDROCK2
SCHEMBL123496 0.91 PRKACA (1.00) PRKACAPRKCGPRKCZPRKCDROCK2
SCHEMBL9587855 0.91 PRKACA (0.82) PRKACAPRKCGPRKCZPRKCDROCK2
SCHEMBL9587853 0.91 PRKACA (0.82) PRKACAPRKCGPRKCZPRKCDROCK2
Bromide SCHEMBL3347119 0.90 PRKACA (0.98) PRKACAPRKCGPRKCZPRKCDROCK2
Hydrochloric Acid SCHEMBL1048974 0.90 PRKACA (1.00) PRKACAPRKCGPRKCZPRKCDROCK2
Hydrochloric Acid SCHEMBL29967768 0.90 PRKACA (1.00) PRKACAPRKCGPRKCZPRKCDROCK2
Hydrochloric Acid SCHEMBL905696 0.90 PRKACA (1.00) PRKACAPRKCGPRKCZPRKCDROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7826979-B2 Method of modeling complex formation between a query ligan and a target molecule VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-11-02 US disclosed
US-7826979-B2 Method of modeling complex formation between a query ligan and a target molecule VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-11-02 US disclosed
US-5081246-A Isoquinolino sulfonamino derivatives Hidaka, Hiroyoshi (JP) 1992-01-14 US disclosed